CoChat

Predictive toxicology using systemic biology and liver microfluidic “on chip” approaches: Application to acetaminophen injury

Prot, Jean-Matthieu, Bunescu, Andrei, Elena-Herrmann, Bénédicte, Aninat, Caroline, Snouber, Leila Choucha, Griscom, Laurent, Razan, Florence, Bois, Frederic Y., Legallais, Cécile, Brochot, Céline, Corlu, Anne, Dumas, Marc Emmanuel, Leclerc, Eric · 2012 · Toxicology and Applied Pharmacology
Cited by 71

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

We have analyzed transcriptomic, proteomic and metabolomic profiles of hepatoma cells cultivated inside a microfluidic biochip with or without acetaminophen (APAP). Without APAP, the results show an adaptive cellular response to the microfluidic environment, leading to the induction of anti-oxidative stress and cytoprotective pathways. In presence of APAP, calcium homeostasis perturbation, lipid peroxidation and cell death are observed. These effects can be attributed to APAP metabolism into its highly reactive metabolite, N-acetyl-p-benzoquinone imine (NAPQI). That toxicity pathway was confirmed by the detection of GSH-APAP, the large production of 2-hydroxybutyrate and 3-hydroxybutyrate, and methionine, cystine, and histidine consumption in the treated biochips. Those metabolites have been reported as specific biomarkers of hepatotoxicity and glutathione depletion in the literature. In addition, the integration of the metabolomic, transcriptomic and proteomic collected profiles allowed a more complete reconstruction of the APAP injury pathways. To our knowledge, this work is the first example of a global integration of microfluidic biochip data in toxicity assessment. Our results demonstrate the potential of that new approach to predictive toxicology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.taap.2011.12.017

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • KEGG for representation and analysis of molecular networks involving diseases and drugs

    Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322 · cited 1×

    “We identified significantly perturbed metabolic pathways by mapping transcriptomic, proteomic and metabolomic data signatures using the KEGG database (Kanehisa et al., 2010) and Ingenuity canonical pathways (Ingenuity® Systems).”
    Method
  • Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

    Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · cited 1×

    “…(Nicholson et al., 1999; 2002), is a powerful tool for characterizing variations in the concentration of such compounds in biofluids or organs in response to drug treatments (Clayton et al., 2006), but also to pathophysiology (Dumas et al., 2006) or genetic polymorphisms (Dumas et al., 2007).”
    Self-citation
  • Pharmaco-metabonomic phenotyping and personalized drug treatment

    Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 1×

    “…(Nicholson et al., 1999; 2002), is a powerful tool for characterizing variations in the concentration of such compounds in biofluids or organs in response to drug treatments (Clayton et al., 2006), but also to pathophysiology (Dumas et al., 2006) or genetic polymorphisms (Dumas et al., 2007).”
  • Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor

    Powers, M. J., Janigian, D. M., Wack, K. E., Baker, C. S., Stolz, D. B., & Griffith, L. G. (2002) · Tissue Engineering · doi:10.1089/107632702760184745 · Cited by 234 · cited 2×

    “…organs can now take advantage of recent developments in microtechnology to produce systems on a very small scale (Griffith and Naughton 2002; Powers et al., 2002; Sivaraman et al., 2005; Chao et al., 2010; Prot et al., 2011a; Baudoin et al., 2007; Novik et al., 2010; Baudoin et al., 2011).”
    Background

Cited by

See all 71

Metadata

Authors
Prot, J.-M., Bunescu, A., Elena-Herrmann, B., Aninat, C., Snouber, L. C., Griscom, L., Razan, F., Bois, F. Y., Legallais, C., Brochot, C., Corlu, A., Dumas, M. E., & Leclerc, E.
Venue
Toxicology and Applied Pharmacology
Publisher
Elsevier BV
Published
2012-03
Volume
259
Issue
3
Pages
270-280
ISSN
0041-008X (ISSN-L)
OpenAlex
W1994377711
Cited by
71
References
4
FWCI
5.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.